GWM
VCIT icon

Geneos Wealth Management’s Vanguard Intermediate-Term Corporate Bond ETF VCIT Stock Holding History

Geneos Wealth Management’s Portfolio VCIT Stock Details VCIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$353K Sell
4,266
-215
-5% -$18K 0.01% 795
2025
Q4 		$375K Buy
4,481
+185
+4% +$15.5K 0.01% 745
2025
Q3 		$361K Sell
4,296
-2,951
-41% -$245K 0.01% 746
2025
Q2 		$601K Sell
7,247
-9,837
-58% -$799K 0.01% 659
2025
Q1 		$1.4M Buy
17,084
+9,660
+130% +$781K 0.02% 576
2024
Q4 		$596K Buy
7,424
+138
+2% +$11.3K 0.02% 544
2024
Q3 		$610K Buy
7,286
+3,450
+90% +$284K 0.02% 509
2024
Q2 		$307K Sell
3,836
-2,018
-34% -$160K 0.01% 601
2024
Q1 		$471K Sell
5,854
-2,498
-30% -$200K 0.02% 510
2023
Q4 		$679K Buy
8,352
+822
+11% +$63.5K 0.03% 408
2023
Q3 		$572K Sell
7,530
-280
-4% -$21.8K 0.03% 439
2023
Q2 		$617K Buy
7,810
+1,723
+28% +$137K 0.03% 424
2023
Q1 		$488K Buy
6,087
+1,818
+43% +$144K 0.03% 449
2022
Q4 		$331K Sell
4,269
-1,423
-25% -$109K 0.02% 500
2022
Q3 		$430K Sell
5,692
-2,710
-32% -$217K 0.03% 424
2022
Q2 		$678K Sell
8,402
-192
-2% -$15.7K 0.03% 417
2022
Q1 		$739K Sell
8,594
-4,815
-36% -$427K 0.03% 441
2021
Q4 		$1.24M Buy
13,409
+2,545
+23% +$238K 0.05% 342
2021
Q3 		$1.03M Buy
10,864
+6,816
+168% +$651K 0.04% 375
2021
Q2 		$384K Sell
4,048
-8,846
-69% -$832K 0.02% 632
2021
Q1 		$1.21M Buy
12,894
+210
+2% +$20K 0.03% 376
2020
Q4 		$347K Buy
12,684
+9,121
+256% +$879K 0.01% 638
2020
Q3 		$340K Sell
3,563
-180
-5% -$17.3K 0.02% 525
2020
Q2 		$354K Sell
3,743
-239
-6% -$22K 0.02% 494
2020
Q1 		$341K Sell
3,982
-849
-18% -$77.2K 0.02% 459
2019
Q4 		$441K Sell
4,831
-296
-6% -$27K 0.02% 462
2019
Q3 		$467K Sell
5,127
-118
-2% -$10.7K 0.03% 422
2019
Q2 		$471K Buy
5,245
+129
+3% +$11.3K 0.03% 420
2019
Q1 		$444K Buy
5,116
+2,333
+84% +$198K 0.03% 428
2018
Q4 		$229K Sell
2,783
-3,847
-58% -$317K 0.02% 561
2018
Q3 		$553K Buy
6,630
+1,862
+39% +$156K 0.04% 363
2018
Q2 		$398K Sell
4,768
-895
-16% -$74.9K 0.03% 369
2018
Q1 		$480K Sell
5,663
-1,572
-22% -$134K 0.04% 312
2017
Q4 		$632K Sell
7,235
-70,799
-91% -$6.21M 0.06% 276
2017
Q3 		$6.87M Buy
78,034
+70,428
+926% +$6.2M 0.68% 28
2017
Q2 		$665K Buy
7,606
+107
+1% +$9.34K 0.07% 243
2017
Q1 		$647K Buy
7,499
+1,190
+19% +$102K 0.07% 227
2016
Q4 		$540K Sell
6,309
-195
-3% -$17K 0.07% 231
2016
Q3 		$582K Sell
6,504
-198
-3% -$17.7K 0.08% 225
2016
Q2 		$598K Sell
6,702
-7,106
-51% -$623K 0.09% 214
2016
Q1 		$1.2M Buy
+13,808
New +$1.17M 0.18% 129

Other funds holding VCIT

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Geneos Wealth Management's VCIT Position: Q1 2026 in Review

Geneos Wealth Management reduced its Vanguard Intermediate-Term Corporate Bond ETF (VCIT) stake by 4.8% in Q1 2026, selling an estimated $18K and leaving 4,266 shares worth $353K. The position accounts for 0.01% of the portfolio, ranked #795.

Geneos Wealth Management first reported a position in VCIT in Q1 2016 and has held it in 41 quarters since. The position peaked at $6.87M in Q3 2017. 1,357 funds tracked by Wall St. Rank hold VCIT as of Q1 2026.

  • Geneos Wealth Management held 4,266 shares of Vanguard Intermediate-Term Corporate Bond ETF worth $353K as of Q1 2026.
  • Geneos Wealth Management sold 215 Vanguard Intermediate-Term Corporate Bond ETF shares in Q1 2026, an estimated $18K.
  • Vanguard Intermediate-Term Corporate Bond ETF made up 0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #795 holding.
  • Geneos Wealth Management first reported a position in Vanguard Intermediate-Term Corporate Bond ETF in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's Vanguard Intermediate-Term Corporate Bond ETF position peaked at $6.87M in Q3 2017.
  • 1,357 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Corporate Bond ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.